Post-traumatic Stress Disorder: A Narrative Review of Pharmacological and Psychotherapeutic Interventions

Overview

Journal Cureus

Specialty Biomedical Engineering

Date 2023 Oct 10

PMID 37814755

Authors

Mohammad Mansour

Geethi Rose Joseph

Golda K Joy

Shandesh Khanal

Rachana Reddy Dasireddy

Aardra Menon

Iyesatu Barrie Mason

Janvi Kataria

Tirath Patel

Shivani Modi

Affiliations

Soon will be listed here.

Abstract

Post-traumatic stress disorder (PTSD) is a complex mental health condition affecting individuals exposed to traumatic events. This paper is a narrative review of the existing literature on pharmacological and psychotherapeutic interventions for PTSD. Treatment includes selective serotonin reuptake inhibitors (SSRIs), serotonin-norepinephrine reuptake inhibitors (SNRIs), and alpha-1 adrenergic receptor antagonists. By exploring the outcomes of these interventions, the review seeks to provide valuable insights into their potential as PTSD treatment options. The paper also highlights the importance of tailoring treatment plans to individual needs and discusses emerging treatments, such as mindfulness-based therapies, virtual reality therapy, and neurostimulation techniques. By integrating findings from various studies, it aims to offer valuable information to optimize treatment strategies and enhance outcomes for individuals suffering from PTSD. The goal is to support informed decision-making, ultimately leading to more effective and tailored approaches to address the challenges posed by this debilitating condition.

Citing Articles

Sex and Age Differences in Glucocorticoid Signaling After an Aversive Experience in Mice.

Li Y, Zhang B, Yang Y, Su P, Samsom J, Wong A Cells. 2025; 13(24.

PMID: 39768133 PMC: 11674875. DOI: 10.3390/cells13242041.

Early biological and psychosocial factors associated with PTSD onset and persistence in youth.

Williams K, Nto N, Jansen Van Vuren E, Sallie F, Molebatsi K, Kroneberg K Eur J Psychotraumatol. 2024; 15(1):2432160.

PMID: 39648852 PMC: 11632931. DOI: 10.1080/20008066.2024.2432160.

Psychological Well-Being and Quality of Life in Laryngeal Cancer Patients across Tumor.

Murariu M, Boia E, Horhat D, Mot C, Balica N, Trebuian C J Clin Med. 2024; 13(20).

PMID: 39458088 PMC: 11508364. DOI: 10.3390/jcm13206138.

New Insights into Contradictory Changes in Brain-Derived Neurotrophic Factor (BDNF) in Rodent Models of Posttraumatic Stress Disorder (PTSD).

Ghaffarzadegan R, Akhondzadeh S, Nikasa Z, Hajizamani S, Mehrabanifar S, Cheraghi I Neurochem Res. 2024; 49(12):3226-3243.

PMID: 39283581 DOI: 10.1007/s11064-024-04242-5.

The Use of Compounds Derived from in the Treatment of Epilepsy, Painful Conditions, and Neuropsychiatric and Neurodegenerative Disorders.

Stasilowicz-Krzemien A, Nogalska W, Maszewska Z, Maleszka M, Dobron M, Szary A Int J Mol Sci. 2024; 25(11).

PMID: 38891938 PMC: 11171823. DOI: 10.3390/ijms25115749.

References

Ressler K, Berretta S, Bolshakov V, Rosso I, Meloni E, Rauch S . Post-traumatic stress disorder: clinical and translational neuroscience from cells to circuits. Nat Rev Neurol. 2022; 18(5):273-288. PMC: 9682920. DOI: 10.1038/s41582-022-00635-8. View

Bisson J, Roberts N, Andrew M, Cooper R, Lewis C . Psychological therapies for chronic post-traumatic stress disorder (PTSD) in adults. Cochrane Database Syst Rev. 2013; (12):CD003388. PMC: 6991463. DOI: 10.1002/14651858.CD003388.pub4. View

Coventry P, Meader N, Melton H, Temple M, Dale H, Wright K . Psychological and pharmacological interventions for posttraumatic stress disorder and comorbid mental health problems following complex traumatic events: Systematic review and component network meta-analysis. PLoS Med. 2020; 17(8):e1003262. PMC: 7446790. DOI: 10.1371/journal.pmed.1003262. View

Davidson J, Baldwin D, Stein D, Kuper E, Benattia I, Ahmed S . Treatment of posttraumatic stress disorder with venlafaxine extended release: a 6-month randomized controlled trial. Arch Gen Psychiatry. 2006; 63(10):1158-65. DOI: 10.1001/archpsyc.63.10.1158. View

Dunlop B, Mansson E, Gerardi M . Pharmacological innovations for posttraumatic stress disorder and medication- enhanced psychotherapy. Curr Pharm Des. 2012; 18(35):5645-58. DOI: 10.2174/138161212803530899. View

Hoskins M, Sinnerton R, Nakamura A, Underwood J, Slater A, Lewis C . Pharmacological-assisted Psychotherapy for Post-Traumatic Stress Disorder: a systematic review and meta-analysis. Eur J Psychotraumatol. 2021; 12(1):1853379. PMC: 7874936. DOI: 10.1080/20008198.2020.1853379. View

Campbell M, Decker K, Kruk K, Deaver S . Art Therapy and Cognitive Processing Therapy for Combat-Related PTSD: A Randomized Controlled Trial. Art Ther (Alex). 2018; 33(4):169-177. PMC: 5764181. DOI: 10.1080/07421656.2016.1226643. View

Myers K, Davis M . Mechanisms of fear extinction. Mol Psychiatry. 2006; 12(2):120-50. DOI: 10.1038/sj.mp.4001939. View

Krystal J, Rosenheck R, Cramer J, Vessicchio J, Jones K, Vertrees J . Adjunctive risperidone treatment for antidepressant-resistant symptoms of chronic military service-related PTSD: a randomized trial. JAMA. 2011; 306(5):493-502. DOI: 10.1001/jama.2011.1080. View

10.

Kar N . Cognitive behavioral therapy for the treatment of post-traumatic stress disorder: a review. Neuropsychiatr Dis Treat. 2011; 7:167-81. PMC: 3083990. DOI: 10.2147/NDT.S10389. View

11.

Khachatryan D, Groll D, Booij L, Sepehry A, Schutz C . Prazosin for treating sleep disturbances in adults with posttraumatic stress disorder: a systematic review and meta-analysis of randomized controlled trials. Gen Hosp Psychiatry. 2015; 39:46-52. DOI: 10.1016/j.genhosppsych.2015.10.007. View

12.

Raskind M, Peskind E, Chow B, Harris C, Davis-Karim A, Holmes H . Trial of Prazosin for Post-Traumatic Stress Disorder in Military Veterans. N Engl J Med. 2018; 378(6):507-517. DOI: 10.1056/NEJMoa1507598. View

13.

Cipriani A, Williams T, Nikolakopoulou A, Salanti G, Chaimani A, Ipser J . Comparative efficacy and acceptability of pharmacological treatments for post-traumatic stress disorder in adults: a network meta-analysis. Psychol Med. 2017; 48(12):1975-1984. DOI: 10.1017/S003329171700349X. View

14.

Abdallah C, Averill L, Akiki T, Raza M, Averill C, Gomaa H . The Neurobiology and Pharmacotherapy of Posttraumatic Stress Disorder. Annu Rev Pharmacol Toxicol. 2018; 59:171-189. PMC: 6326888. DOI: 10.1146/annurev-pharmtox-010818-021701. View

15.

Strawbridge R, Carter B, Marwood L, Bandelow B, Tsapekos D, Nikolova V . Augmentation therapies for treatment-resistant depression: systematic review and meta-analysis. Br J Psychiatry. 2018; 214(1):42-51. DOI: 10.1192/bjp.2018.233. View

16.

Forbes D, Creamer M, Bisson J, Cohen J, Crow B, Foa E . A guide to guidelines for the treatment of PTSD and related conditions. J Trauma Stress. 2010; 23(5):537-52. DOI: 10.1002/jts.20565. View

17.

Watts B, Schnurr P, Mayo L, Young-Xu Y, Weeks W, Friedman M . Meta-analysis of the efficacy of treatments for posttraumatic stress disorder. J Clin Psychiatry. 2013; 74(6):e541-50. DOI: 10.4088/JCP.12r08225. View

18.

Tarrier N, Liversidge T, Gregg L . The acceptability and preference for the psychological treatment of PTSD. Behav Res Ther. 2006; 44(11):1643-56. DOI: 10.1016/j.brat.2005.11.012. View

19.

Bradley R, Greene J, Russ E, Dutra L, Westen D . A multidimensional meta-analysis of psychotherapy for PTSD. Am J Psychiatry. 2005; 162(2):214-27. DOI: 10.1176/appi.ajp.162.2.214. View

20.

Cusack K, Jonas D, Forneris C, Wines C, Sonis J, Middleton J . Psychological treatments for adults with posttraumatic stress disorder: A systematic review and meta-analysis. Clin Psychol Rev. 2015; 43:128-41. DOI: 10.1016/j.cpr.2015.10.003. View